Randomized clinical trials in advanced and metastatic colorectal carcinoma

Michael I. D'Angelica; Margo C. Shoup; Aviram Nissan

doi:10.1016/S1055-3207(03)00080-2

Randomized clinical trials in advanced and metastatic colorectal carcinoma

Michael I. D'Angelica^*, Margo C. Shoup, Aviram Nissan

^*Corresponding author for this work

Surgery

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

The treatment of advanced colorectal cancer has long been a dilemna for clinicians. After many years of therapy limited to 5-fluorouracil (5-FU)-based chemotherapy, a number of new discoveries have significantly advanced this field in the last decade. The advent of irinotecan has given us hope for a second line chemotherapeutic agent and a possible new combination for first line chemotherapy.

Original language	English (US)
Pages (from-to)	173-191
Number of pages	19
Journal	Surgical Oncology Clinics of North America
Volume	11
Issue number	1
DOIs	https://doi.org/10.1016/S1055-3207(03)00080-2
State	Published - 2002

ASJC Scopus subject areas

Surgery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1055-3207(03)00080-2

Cite this

@article{9b4fe47ab1d042fa85594abc88f5fdd9,

title = "Randomized clinical trials in advanced and metastatic colorectal carcinoma",

abstract = "The treatment of advanced colorectal cancer has long been a dilemna for clinicians. After many years of therapy limited to 5-fluorouracil (5-FU)-based chemotherapy, a number of new discoveries have significantly advanced this field in the last decade. The advent of irinotecan has given us hope for a second line chemotherapeutic agent and a possible new combination for first line chemotherapy.",

author = "D'Angelica, {Michael I.} and Shoup, {Margo C.} and Aviram Nissan",

year = "2002",

doi = "10.1016/S1055-3207(03)00080-2",

language = "English (US)",

volume = "11",

pages = "173--191",

journal = "Surgical Oncology Clinics of North America",

issn = "1055-3207",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Randomized clinical trials in advanced and metastatic colorectal carcinoma

AU - D'Angelica, Michael I.

AU - Shoup, Margo C.

AU - Nissan, Aviram

PY - 2002

Y1 - 2002

N2 - The treatment of advanced colorectal cancer has long been a dilemna for clinicians. After many years of therapy limited to 5-fluorouracil (5-FU)-based chemotherapy, a number of new discoveries have significantly advanced this field in the last decade. The advent of irinotecan has given us hope for a second line chemotherapeutic agent and a possible new combination for first line chemotherapy.

AB - The treatment of advanced colorectal cancer has long been a dilemna for clinicians. After many years of therapy limited to 5-fluorouracil (5-FU)-based chemotherapy, a number of new discoveries have significantly advanced this field in the last decade. The advent of irinotecan has given us hope for a second line chemotherapeutic agent and a possible new combination for first line chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0036135120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036135120&partnerID=8YFLogxK

U2 - 10.1016/S1055-3207(03)00080-2

DO - 10.1016/S1055-3207(03)00080-2

M3 - Review article

C2 - 11928799

AN - SCOPUS:0036135120

SN - 1055-3207

VL - 11

SP - 173

EP - 191

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

IS - 1

ER -

Randomized clinical trials in advanced and metastatic colorectal carcinoma

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this